Lates News

Every AI Express News, Haitong International released a research report on November 12th, giving Aibo Medical (688050.SH) a "neutral" rating with a target price of 70.65 yuan. The reasons for the rating mainly include: 1) the company's profit in the first three quarters is under pressure, mainly due to increased competition in the artificial intraocular lens and contact lens industries; 2) the decline in net profit attributable to the parent company is mainly due to the decline in revenue from artificial intraocular lenses and contact lenses, as well as the company's increased promotion of its own brand of contact lenses; 3) in terms of artificial intraocular lenses, affected by the adjustment of the national centralized procurement and the structure of medical insurance expenditures in some provinces and cities, the company's revenue and sales volume of artificial intraocular lenses have both decreased compared to the same period in 2024; 4) in terms of contact lenses, influenced by the consumption market environment, terminal prices have declined, and with the intensification of competition due to the expansion of domestic production capacity, both the factory prices and profit margins of contact lenses have decreased. (Daily Economic News)